Enzymatic synthesis of sialyl Lex and derivatives based on a recombinant fucosyltransferase
dc.contributor.author | Dumas, David P. | en_US |
dc.contributor.author | Ichikawa, Yoshitaka | en_US |
dc.contributor.author | Wong, Chi-Huey | en_US |
dc.contributor.author | Lowe, John B. | en_US |
dc.contributor.author | Nair, Rajan P. | en_US |
dc.date.accessioned | 2006-04-10T14:54:53Z | |
dc.date.available | 2006-04-10T14:54:53Z | |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Dumas, David P., Ichikawa, Yoshitaka, Wong,, Chi-Huey, Lowe,, John B., Nair, Rajan P. (1991)."Enzymatic synthesis of sialyl Lex and derivatives based on a recombinant fucosyltransferase." Bioorganic & Medicinal Chemistry Letters 1(8): 425-428. <http://hdl.handle.net/2027.42/29619> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TF9-42K6HD5-8N/2/b697eb5cd9621c3a00f61a56909d39fd | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29619 | |
dc.description.abstract | A recombinant human Lewis [alpha](1,3/1,4)fucosyltranferase has been studied for its acceptor substrate specificity and used in the synthesis of sialyl Lex and derivatives. | en_US |
dc.format.extent | 247874 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Enzymatic synthesis of sialyl Lex and derivatives based on a recombinant fucosyltransferase | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical Center Ann Arbor, MI 48109-0650 U.S.A.; Howard Hughes Medical Institute, University of Michigan Medical Center Ann Arbor, MI 48109-0650 U.S.A. | en_US |
dc.contributor.affiliationum | Howard Hughes Medical Institute, University of Michigan Medical Center Ann Arbor, MI 48109-0650 U.S.A. | en_US |
dc.contributor.affiliationother | Department of Chemistry, The Scripps Research Institute La Jolla, CA 92037 U.S.A. | en_US |
dc.contributor.affiliationother | Department of Chemistry, The Scripps Research Institute La Jolla, CA 92037 U.S.A. | en_US |
dc.contributor.affiliationother | Department of Chemistry, The Scripps Research Institute La Jolla, CA 92037 U.S.A. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29619/1/0000708.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/S0960-894X(00)80270-X | en_US |
dc.identifier.source | Bioorganic & Medicinal Chemistry Letters | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.